Episode Synopsis "NHS MedTech Market Access Engagement Post Covid 19 Series"

CEO of Device Access UK, Michael Branagan-Harris gathers a panel of NHS management to discuss the future of MedTech Engagement with the NHS in the wake of Covid-19 and how best to approach it. Device Access UK helps MedTech companies all over the world demonstrate the true value of their device, to help in getting great technologies to patients faster. 

Listen "NHS MedTech Market Access Engagement Post Covid 19 Series"

More episodes of the podcast Device Access UK Ltd's Podcast

• MedTech Opportunities in 2022 as NHS Hospital Waiting List Pressure Grows
• How the NHS Carbon Neutral Agenda Affects the MedTech Industry
• MedTech Opportunities as NHS Hospital Waiting List Pressure Grows
• How to successfully navigate UK NHS procurement and tendering for MedTech
• The Benefits and opportunities of entering the UK Market with MedTech Post Brexit & Successful Case Studies
• Accelerating MedTech Evidence Generation with the NIHR
• The Use of Real World Evidence to Accelerate MedTech HTA Approval
• How to Accelerate MedTech Sales into UK Private Hospitals
• The Power of the Patient's Voice in NHS MedTech Adoption.
• Value Based Healthcare Solutions for MedTech
• Reducing Your Investment Risk in Start-Up MedTech
• Accelerating MedTech Adoption into the NHS
• Understanding NICE and MedTech Evaluations
• Re-Opening of Elective Surgery in the NHS
• NHS MedTech Market Access Engagement Post Covid 19 Series